KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Equity Average (2019 - 2025)

Historic Equity Average for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $621.9 million.

  • GoodRx Holdings' Equity Average fell 893.89% to $621.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $621.9 million, marking a year-over-year decrease of 893.89%. This contributed to the annual value of $743.3 million for FY2024, which is 571.85% down from last year.
  • As of Q3 2025, GoodRx Holdings' Equity Average stood at $621.9 million, which was down 893.89% from $648.7 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Equity Average registered a high of $888.3 million during Q3 2023, and its lowest value of $621.9 million during Q3 2025.
  • In the last 5 years, GoodRx Holdings' Equity Average had a median value of $801.6 million in 2022 and averaged $763.2 million.
  • In the last 5 years, GoodRx Holdings' Equity Average soared by 71806.49% in 2021 and then crashed by 2451.6% in 2024.
  • Over the past 5 years, GoodRx Holdings' Equity Average (Quarter) stood at $839.0 million in 2021, then dropped by 4.46% to $801.6 million in 2022, then grew by 2.5% to $821.6 million in 2023, then fell by 13.52% to $710.5 million in 2024, then dropped by 12.48% to $621.9 million in 2025.
  • Its Equity Average stands at $621.9 million for Q3 2025, versus $648.7 million for Q2 2025 and $689.5 million for Q1 2025.